UBS Oracle · ORCL

UBS Raises Oracle Price Target to $250

Analyst: Karl Keirstead 1 min read Reproduced verbatim
Rating
Buy
Target
$250
from $245 (+2%)
Upside
+115%
ORCL at $116 today
UBS and Oracle logos

What the analyst said

UBS analyst Karl Keirstead raised the price target on Oracle (NYSE: ORCL) to $250 (from $245) while maintaining a Buy rating.

“The +4% after-market reaction in Oracle shares strikes us as reasonable given what we conclude was a quarter marked by the positives (1Q/Aug revs and EPS beat, guide for further cloud infra acceleration, completion of ATM/secondary) offsetting the negatives (no FY27 revs guide raise).

Net, the material AI-driven growth acceleration (30% revs growth from 11% a year-ago) is playing out. We remain Buy-rated.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $116. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $250 target is 8% above the median.

Since the note ORCL has moved −24% (from $153). 12-month window: day 56 of 365, closes on September 11, 2027.

Track record

This callOpen: ORCL has not reached $250 yet. This 12-month target is scored on September 11, 2027.

Firm track recordUBS: 81% of its 54 targets at least a year old were reached within 12 months (#9 of 26 firms). Accuracy ranking →

Earnings reactionOne of 12 notes after Oracle’s Sep 10 results: 2 raised · 4 cut · 6 kept. See every call →

UBS on Oracle

UBS price targets on Oracle

6 calls from January 5, 2026 to September 11, 2026. The target went from $280 to $250 (−11%). The rating stayed Buy.

UBS targetORCL share price
  1. September 11, 2026 This noteTarget raised from $245 (+2%)Buy$250
  2. August 6, 2026Target cut from $285 (−14%)Buy$245
  3. June 2, 2026Target raised from $250 (+14%)Buy$285
  4. April 7, 2026Kept the $250 targetBuy$250
  5. February 2, 2026Target cut from $280 (−11%)Buy$250
  6. January 5, 2026Earliest call shownBuy$280
Share

Other analysts on Oracle

ScotiabankBuy Cut price target −5%, kept rating Oct 29 $205from $215 GuggenheimBuy Kept rating and price target Oct 29 $400maintained OppenheimerBuy Kept rating and price target Oct 29 $275maintained BairdBuy Kept rating and price target Oct 29 $215maintained Melius ResearchBuy Kept rating and price target Oct 29 $170maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.